Not every company that sells a medical device manufactures it from the ground up in-house. OEM (original equipment manufacturer) and contract manufacturing arrangements allow businesses to bring devices to market by partnering with an established manufacturing organization. This article explains OEM and contract manufacturing in medical devices at a conceptual level for B2B and procurement audiences.
What Is the Difference Between OEM and Contract Manufacturing?
While the terms are sometimes used loosely, they generally describe related but distinct arrangements:
- Contract manufacturing typically refers to a manufacturer producing a device according to another company's design specifications, with the commissioning company retaining ownership of the design and often the regulatory registration
- OEM arrangements often involve a manufacturer producing devices — sometimes based on its own existing platform designs — that are then sold under another company's brand, sometimes described as private-label manufacturing
In practice, these models can overlap, and specific contractual terms determine exactly how design ownership, regulatory responsibility, and branding are divided between the parties involved.
Why Do Companies Pursue OEM or Contract Manufacturing Relationships?
Businesses enter these arrangements for several common reasons. A company may want to bring a device to market without building its own manufacturing infrastructure, cleanroom facilities, and ISO 13485-certified quality system from scratch — a capital-intensive undertaking. Established manufacturers with existing regulatory certifications and production capacity can offer significantly faster paths to market than starting manufacturing operations independently. Some businesses also use these partnerships to access specialized manufacturing capabilities, such as precision laser cutting, electropolishing, or coating processes, that would be inefficient to develop internally for a single product line.
What Regulatory Responsibilities Apply in These Arrangements?
Regulatory responsibility in OEM and contract manufacturing relationships must be clearly defined in the governing agreement. Under EU MDR 2017/745, the entity legally identified as the "manufacturer" — the party that holds primary regulatory responsibility, whether that is the original design owner or the entity selling under its own brand — bears specific obligations, including maintaining technical documentation, ensuring the quality management system meets ISO 13485 principles, and managing post-market surveillance and vigilance reporting.
Because of this, due diligence on the actual manufacturing partner's certifications, facility capabilities, and regulatory track record remains essential even when a separate brand appears on the finished packaging.
What Should Businesses Evaluate Before Entering an OEM or Contract Manufacturing Agreement?
Companies considering this path typically assess:
- Manufacturing capability match — whether the partner's existing equipment, materials expertise, and process validation experience align with the device being produced
- Quality system maturity — confirmed ISO 13485 certification scope and a track record of successful regulatory audits
- Intellectual property protections — clear contractual terms addressing design ownership, confidentiality, and use of proprietary technology
- Capacity and scalability — whether the manufacturing partner can support projected volume growth over time
- Regulatory support — the extent to which the manufacturing partner assists with technical documentation, testing, and conformity assessment activities
Frequently Asked Questions
Does a contract-manufactured device still need to be CE marked?
Yes. Regardless of the manufacturing arrangement, any device placed on the EU market must meet applicable EU MDR 2017/745 requirements and carry valid CE marking, with regulatory responsibility clearly assigned per the governing agreement.
Can a single manufacturing facility produce devices for multiple brands?
Yes, this is a common model in the industry. A facility's ISO 13485 quality system typically governs production across multiple product lines and customer brands, provided each is appropriately documented and controlled.
What is the advantage of partnering with an established manufacturer versus building new facilities?
Partnering with an established, certified manufacturer can significantly reduce the time and capital investment required to bring a device to market, leveraging existing regulatory certifications, validated processes, and manufacturing infrastructure rather than developing them independently.
Related INVAMED Resources
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.